Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-743 in Parkinson's Disease
NCT01923584Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Sep 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatiquinone in Parkinson's disease (PD), sponsored by University of South Florida. Started Sep 2013; status: completed.
02
Drugs
vatiquinone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01923584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923584.